Donor oocytes can be used to overcome female infertility owing to ovarian causes and to decrease the burden of certain genetic diseases. We have established an anonymous, matched, fertile donor oocyte programme under the University of Iowa intemal review board's approval and oversight. Donors are screened for sexually transmitted and genetic diseases, and phenotypic characteristics of the donors and recipients are then matched as much as possible according to a priority list made by the recipient. So far, four women Although the precise aetiology of these malformations was unknown, the findings of genitourinary tract anomalies in the mother, her two children, and her nephew suggested the possibility she was a carrier for an X linked recessive mutation.
After extensive counselling, she entered our donor oocyte programme. An anonymous donor with no history of genetic diseases was matched phenotypically with recipient characteristics. The donor underwent a programmed combined clomiphene citrate/human menopausal gonadotrophin stimulation regimen. Thirty-six hours after an ovulatory dose of human chorionic gonadotrophin (hCG), a total of 12 mature oocytes was retrieved. Nine out of the 12 oocytes were fertilised and, 24 hours later, three pronuclear stage embryos were transferred into the recipient's fallopian tube under laparoscopic guidance. The recipient's endometrium was synchronised to the donor's cycle by GnRH-agonist suppression followed by oestrogen and progesterone replacement therapy as described by Meldrum et 
